|
Market Closed -
Nasdaq
02:30:00 14/02/2026 am IST
|
5-day change
|
1st Jan Change
|
|
803.17 USD
|
+2.49%
|
 |
+2.25%
|
+4.06%
|
|
01/25/01 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $4,252,745, According to a Recent SEC Filing
|
MT
| |
20/25/20 |
PRESS DIGEST-Wall Street Journal - May 20
|
RE
| |
04/24/04 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,054,060, According to a Recent SEC Filing
|
MT
| |
30/24/30 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $6,846,262, According to a Recent SEC Filing
|
MT
| |
20/24/20 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $12,552,285, According to a Recent SEC Filing
|
MT
| |
16/24/16 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $7,337,505, According to a Recent SEC Filing
|
MT
| |
23/24/23 |
BridgeBio Pharma, Inc. Announces Executive Changes
|
CI
| |
03/24/03 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,190,564, According to a Recent SEC Filing
|
MT
| |
14/24/14 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $25,610,229, According to a Recent SEC Filing
|
MT
| |
18/24/18 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $48,636,545, According to a Recent SEC Filing
|
MT
| |
16/24/16 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $35,207,110, According to a Recent SEC Filing
|
MT
| |
16/24/16 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $5,531,290, According to a Recent SEC Filing
|
MT
| |
06/24/06 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $346,365, According to a Recent SEC Filing
|
MT
| |
27/24/27 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $3,387,500, According to a Recent SEC Filing
|
MT
| |
13/24/13 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $4,689,320, According to a Recent SEC Filing
|
MT
| |
10/24/10 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $950,000, According to a Recent SEC Filing
|
MT
| |
07/24/07 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $934,710, According to a Recent SEC Filing
|
MT
| |
03/24/03 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $258,152, According to a Recent SEC Filing
|
MT
| |
01/24/01 |
Regeneron Pharmaceuticals, Inc. Appoints Jason Pitofsky as Controller, Expects to Occur on February 5, 2024
|
CI
| |
30/24/30 |
Regeneron Pharmaceuticals, Inc. Appoints Philip Gregory as Senior Vice President and Head of Regeneron Cell Medicines
|
CI
| |
26/24/26 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $2,571,650, According to a Recent SEC Filing
|
MT
| |
05/24/05 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,005,300, According to a Recent SEC Filing
|
MT
| |
05/24/05 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $754,964, According to a Recent SEC Filing
|
MT
| |
07/23/07 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $5,342,787, According to a Recent SEC Filing
|
MT
| |
16/23/16 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $5,188,213, According to a Recent SEC Filing
|
MT
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
